You are here

Emgality

After Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly

Fierce Pharma

Tue, 08/20/24 - 11:34 am

After migraine accord with Eli Lilly, Organon CEO scouts more deals to bolster growth

Fierce Pharma

Fri, 02/16/24 - 11:45 am

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case

Reuters

Tue, 09/26/23 - 09:49 pm

Teva Pharmaceutical

Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec

BioSpace

Mon, 06/19/23 - 10:31 am

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Fierce Pharma

Thu, 11/18/21 - 11:03 pm

clinical trials

As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth

Fierce Pharma

Tue, 10/26/21 - 11:54 pm

Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug

BioSpace

Mon, 08/16/21 - 10:15 pm

Teva Pharmaceutical

Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio

Fierce Pharma

Wed, 07/7/21 - 10:29 pm

pharma marketing

Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study

Fierce Pharma

Tue, 06/15/21 - 10:35 am

Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'

Fierce Pharma

Wed, 06/17/20 - 09:52 pm

Teva Pharmaceutical

Lilly launches real-world study to benchmark Emgality against migraine rivals

Fierce Pharma

Wed, 12/18/19 - 11:54 pm

real world evidence

Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share

Fierce Pharma

Thu, 09/5/19 - 10:37 am

Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study

Endpoints

Mon, 08/5/19 - 10:59 am

clinical trials

chronic migraine

episodic migraine

Lilly's Emgality powers ahead with 'best-in-class' CGRP access

Fierce Pharma

Tue, 07/30/19 - 04:21 pm

Teva Pharmaceutical

Emgality-maker Lilly courts payers with new migraine ER data

Fierce Pharma

Fri, 07/12/19 - 12:22 pm

cluster headache

Teva Pharmaceutical

Lilly enlists patients to raise cluster headache awareness after Emgality scores second nod

Fierce Pharma

Wed, 06/26/19 - 04:56 pm

cluster headaches

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

TheStreet.com

Thu, 06/6/19 - 09:36 am

cluster headaches

Lilly's scored its cluster headache nod for Emgality. Will it shake up the CGRP race?

Fierce Pharma

Wed, 06/5/19 - 12:04 am

cluster headaches

How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says

Fierce Pharma

Tue, 05/14/19 - 04:55 pm

Teva Pharmaceutical

DTC advertising

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

Yahoo/Reuters

Sat, 05/11/19 - 12:10 pm

Teva Pharmaceutical

Pages